Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Oscar Juan-Vidal

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Articles (24)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

David Carbone

Ohio State University Medical Center

UNITED STATES

View details

Francisco Ayala de la Peña

Profesor Asociado

Universidad Complutense de Madrid

SPAIN

View details

Angel Artal

Head of Section

Mie University Hospital

SPAIN

View details

Eloisa Jantus Lewintre

Profesora titular

Universitat Politècnica de València

SPAIN

View details

Takayuki Takahama

Lecturer

Kindai University Hospital

JAPAN

View details

Javier De Castro

Scientific Director

La Paz University Hospital

SPAIN

View details

Geoffrey Liu

Professor

University of Toronto

CANADA

View details

Lorenzo Antonuzzo

University of Florence

ITALY

View details

Vanesa GREGORC

Candiolo Cancer Institute

ITALY

View details

Jun Zhang

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

Se Hyun Kim

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oscar Juan-Vidal

Research Interests

Explore related searches

Articles (24)

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib

Oncological needs in transgender patients

Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab

Adagrasib versus docetaxel in KRAS G12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.

NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC

Efficacy and safety of lorlatinib in patients with ALK-and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial

Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA

Sevabertinib in Advanced <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)

A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis

Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital

Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for <i>EGFR</i>-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients

Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an <i>EGFR</i> Mutated Advanced Non-Small Cell Lung Cancer: A Case Report

Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. <i>Cancers</i> 2021, <i>13</i>, 2980

Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial

Collaborators (11)

David Carbone

Francisco Ayala de la Peña

Angel Artal

Eloisa Jantus Lewintre

Takayuki Takahama

Javier De Castro

Geoffrey Liu

Lorenzo Antonuzzo

Vanesa GREGORC

Jun Zhang

Se Hyun Kim

Make your next move.